Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “solriamfetol”

25 pharma patents match "solriamfetol" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 25
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 25 pharmaceutical patents matching "solriamfetol" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

25 results for “solriamfetol” · 30,257 patents in full index Clear search

  1. US 12318362

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  2. US 12263145

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Apr 1, 2025 · Expires Mar 27, 2045

    granted
  3. US 12194016

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  4. US 12102609

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  5. US 12090126

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Sep 17, 2024 · Expires Sep 12, 2044

    granted
  6. US 12064411

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Aug 20, 2024 · Expires Aug 15, 2044

    granted
  7. US 12036194

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  8. US 12005036

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  9. US 11986455

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted May 21, 2024 · Expires May 16, 2044

    granted
  10. US 11986454

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted May 21, 2024 · Expires May 16, 2044

    granted
  11. US 11969404

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted
  12. US 11872204

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  13. US 11872203

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  14. US 11857528

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted
  15. US 11850226

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted Dec 26, 2023 · Expires Dec 21, 2043

    granted
  16. US 11850228

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted Dec 26, 2023 · Expires Dec 21, 2043

    granted
  17. US 11850227

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted Dec 26, 2023 · Expires Dec 21, 2043

    granted
  18. US 11839599

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  19. US 11839598

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  20. US 11793776

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  21. US 11779554

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted
  22. US 11771666

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  23. US 11771667

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  24. US 11160779

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    Jazz Pharmaceuticals Ireland Limited · Granted Nov 2, 2021 · Expires Oct 28, 2041

    granted